Aspire Biopharma Holdings, Inc.
ASBPW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847345
No open-market purchases or sales by Aspire Biopharma Holdings, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $145.4K in total; no superinvestor holds it.
Other share classesASBP
13F holders, Q3 2024
Institutional positions in Aspire Biopharma Holdings, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- −2 vs. Q2 2024
- Shares held
- 7.55M
- −583.5K (−7.2%) vs. Q2 2024
- Total value
- $343.1K
- +$55.3K (+19.2%) vs. Q2 2024
- New holders
- 4
- 1 more added
- Sold out
- 6
- 2 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ASBPW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $145.4K |
| Q1 2026 | 31 | $121.7K |
| Q4 2025 | 31 | $142.5K |
| Q3 2025 | 31 | $246.3K |
| Q2 2025 | 31 | $395.1K |
| Q1 2025 | 29 | $639.8K |
| Q4 2024 | 28 | $378.3K |
| Q3 2024 | 32 | $343.1K |
| Q2 2024 | 35 | $289.3K |
| Q1 2024 | 36 | $299.9K |
| Q4 2023 | 37 | $590.3K |
| Q3 2023 | 40 | $494.7K |
| Q2 2023 | 41 | $490.5K |
| Q1 2023 | 36 | $399.0K |
| Q4 2022 | 37 | $627.8K |
| Q3 2022 | 37 | $1.28M |
| Q2 2022 | 37 | $1.38M |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Aspire Biopharma Holdings, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Investors Research Corp | 10 | $0 | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 14,183 | $0 | 0.00% | +14,183 | New |
| PEAK6 Investments LLC | 12,500 | $529 | 0.00% | 00.0% | Unchanged |
| Meteora Capital, LLC | 21,000 | $888 | 0.00% | −4,000−16.0% | Reduced |
| Picton Mahoney Asset Management | 50,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| Mint Tower Capital Management B.V. | 25,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 1,050,000 | $1.05K | 0.00% | 00.0% | Unchanged |
| Omers Administration Corp | 25,000 | $1.06K | 0.00% | 00.0% | Unchanged |
| Walleye Trading LLC | 26,190 | $1.11K | 0.00% | 00.0% | Unchanged |
| Cowen and Company, LLC | 28,700 | $1.21K | 0.00% | +28,700 | New |
| Walleye Capital LLC | 46,560 | $1.97K | 0.00% | 00.0% | Unchanged |
| Blue Owl Capital Holdings LP | 50,000 | $2.00K | 0.00% | +50,000 | New |
| Caas Capital Management LP | 75,000 | $3.17K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | – | $4.23K | 0.00% | – | – |
| Clear Street Derivatives LLC | 106,000 | $4.48K | 0.00% | 00.0% | Unchanged |
| Whitebox Advisors LLC | 125,000 | $5.29K | 0.00% | 00.0% | Unchanged |
| Polar Asset Management Partners Inc. | 138,536 | $5.86K | 0.00% | 00.0% | Unchanged |
| Clear Street LLC | 138,566 | $5.86K | 0.00% | +85,567+161.5% | Added |
| Nomura Holdings Inc | 150,000 | $6.30K | 0.00% | 00.0% | Unchanged |
| Context Capital Management, LLC | 175,000 | $7.40K | 0.00% | +175,000 | New |
| D. E. Shaw & Co., Inc. | 199,999 | $8.46K | 0.00% | 00.0% | Unchanged |
| Taconic Capital Advisors LP | 300,000 | $12.7K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 350,000 | $14.8K | 0.00% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 401,544 | $17.0K | 0.00% | 00.0% | Unchanged |
| Verition Fund Management LLC | 432,757 | $18.3K | 0.00% | 00.0% | Unchanged |
| Sculptor Capital LP | 500,000 | $18.9K | 0.00% | 00.0% | Unchanged |
| Periscope Capital Inc. | 556,300 | $23.5K | 0.01% | −262,300−32.0% | Reduced |
| CNH Partners LLC | 647,633 | $27.4K | 0.00% | 00.0% | Unchanged |
| Linden Advisors LP | 899,999 | $34.0K | 0.00% | 00.0% | Unchanged |
| Saba Capital Management, L.P. | 983,603 | $41.6K | 0.00% | 00.0% | Unchanged |
| Highbridge Capital Management LLC | – | $72.0K | 0.00% | – | – |
| Athos Capital Ltd | 21,383 | – | – | 00.0% | Unchanged |
| LMR Partners LLP | 0 | $0 | 0.00% | −125,000−100.0% | Sold out |
| Flow State Investments, L.P. | 0 | $0 | 0.00% | −113,498−100.0% | Sold out |
| Kim, LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Exos Asset Management LLC | 0 | $0 | 0.00% | −137,000−100.0% | Sold out |
| First Pacific Advisors, LP | 0 | $0 | 0.00% | −28,482−100.0% | Sold out |
| Crossingbridge Advisors, LLC | 0 | $0 | 0.00% | −166,667−100.0% | Sold out |
| Atalaya Capital Management LP | – | – | – | – | Not filed |